MoneyWorks4Me

Hester Biosciences informs about statement of investor complaints

05 Oct 2017 Evaluate

Hester Biosciences has informed about Statement Grievance Redressal Mechanism under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the quarter ended on 30 September 2017.

The above information is a part of company’s filings submitted to BSE.

 

Peers
Company Name CMP
Sun Pharma. Inds. 1860.75
Dr. Reddys Labs. 1213.80
Cipla 1375.10
Lupin 2097.70
Zydus Lifesciences 1157.60
View more..